Related Experiment Video
Updated: Jun 27, 2026

Technical Aspects of the Mouse Aortocaval Fistula
Published on: July 11, 2013
Aortoesophageal Fistula: Mending the Lethal Connection-A Systematic Review and Meta-Analysis
Noor Abu Hantash1, Hazem El Beyrouti2, Yousef Alghzawi3
1School of Medicine, University of Jordan, Amman, Jordan; Cardiothoracic Surgery Interest Group, University of Jordan, Amman, Jordan.
Aortoesophageal fistula (AEF) management remains challenging with high mortality. While staged TEVAR followed by surgery improves survival, it increases complications, necessitating individualized, morphology-guided treatment.
Area of Science:
- Vascular Surgery
- Gastroenterology
- Interventional Cardiology
Background:
- Aortoesophageal fistula (AEF) is a rare and life-threatening condition.
- Limited high-quality evidence exists to guide AEF management.
Purpose of the Study:
- To systematically review and analyze survival and complication outcomes for AEF based on treatment strategies and disease severity.
- To compare the efficacy of different management approaches for AEF.
Main Methods:
- Systematic review and meta-analysis of PubMed and Scopus databases up to December 2025.
- Categorization of patients into five treatment groups: TEVAR alone, staged TEVAR with surgery, primary open/hybrid surgery, TEVAR with esophageal stenting, and supportive care.
- Pooled analysis of outcomes, including mortality, infection, reintervention, and recurrence rates.
Main Results:
- Overall 30-day mortality was 31.2% and one-year mortality was 41.2%.
- Staged TEVAR followed by surgery showed improved survival but high infection (66.7%) and reintervention (43.2%) rates.
- TEVAR alone had the lowest one-year mortality (25.5%) among definitive strategies but a high recurrence rate (26.9%). TEVAR with esophageal stenting had low early mortality (5.0%) but high reintervention (54.5%).
- Morphological severity strongly correlated with adverse outcomes, with Type IV lesions having a poor prognosis.
Conclusions:
- AEF continues to have high mortality despite current treatments.
- Definitive management strategies, particularly staged TEVAR and surgery, improve survival but are associated with significant complications.
- Individualized treatment plans guided by AEF morphology are recommended.
Related Concept Videos
Aneurysm III: Interprofessional Care
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
